Clinical Trial Update: To Assess the Safety and Activity of GBR 830, Compared to Placebo, in Adults With Moderate-to-severe Atopic Dermatitis [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating GBR 830 versus placebo in adults with moderate-to-severe atopic dermatitis; study completed with results posted in 2020.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• GBR 830

Snippet

Sponsor: Ichnos Sciences SA | Conditions: Atopic Dermatitis | Phase 2 | Status: COMPLETED | Results posted: 2020-05-18